NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 215 filers reported holding NOVAVAX INC in Q2 2023. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,046 | -39.2% | 3,045 | -41.2% | 0.00% | 0.0% |
| Q2 2023 | $36,260 | +158.4% | 5,180 | +142.5% | 0.00% | 0.0% |
| Q1 2023 | $14,035 | +26890.4% | 2,136 | -69.5% | 0.00% | 0.0% |
| Q4 2022 | $52 | -99.7% | 6,994 | +328.3% | 0.00% | 0.0% |
| Q3 2022 | $20,000 | +122.2% | 1,633 | +435.4% | 0.00% | – |
| Q2 2022 | $9,000 | -25.0% | 305 | -40.3% | 0.00% | – |
| Q1 2022 | $12,000 | -55.6% | 511 | +163.4% | 0.00% | -100.0% |
| Q4 2021 | $27,000 | -48.1% | 194 | -21.1% | 0.00% | 0.0% |
| Q3 2021 | $52,000 | -24.6% | 246 | -23.1% | 0.00% | 0.0% |
| Q2 2021 | $69,000 | +27.8% | 320 | +9.6% | 0.00% | 0.0% |
| Q1 2021 | $54,000 | +50.0% | 292 | -13.1% | 0.00% | 0.0% |
| Q4 2020 | $36,000 | +38.5% | 336 | +39.4% | 0.00% | -50.0% |
| Q3 2020 | $26,000 | – | 241 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | -100.0% | 0.00% | – |
| Q1 2020 | $0 | – | 13 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 132,500 | $2,414,000 | 0.77% |
| HAP Trading, LLC | 130,000 | $10,673,000 | 0.71% |
| Mendel Capital Management LLC | 23,835 | $434,000 | 0.51% |
| Faithward Advisors, LLC | 115,912 | $2,109,000 | 0.50% |
| Rock Springs Capital Management LP | 599,300 | $10,907,000 | 0.28% |
| SECTOR GAMMA AS | 56,735 | $1,033,000 | 0.27% |
| Quantitative Investment Management, LLC | 83,072 | $1,511,000 | 0.25% |
| LMR Partners LLP | 396,100 | $7,209,000 | 0.13% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 1,333,706 | $24,273,000 | 0.13% |
| TSP Capital Management Group, LLC | 16,025 | $292,000 | 0.12% |